| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |